• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于液相色谱-质谱联用技术的结直肠癌组织 N-糖基化研究。

N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.

机构信息

Biomolecular Mass Spectrometry Unit, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Mol Cell Proteomics. 2012 Sep;11(9):571-85. doi: 10.1074/mcp.M111.011601. Epub 2012 May 9.

DOI:10.1074/mcp.M111.011601
PMID:22573871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3434767/
Abstract

Colorectal cancer is the third most common cancer worldwide with an annual incidence of ~1 million cases and an annual mortality rate of ~655,000 individuals. There is an urgent need for identifying novel targets to develop more sensitive, reliable, and specific tests for early stage detection of colon cancer. Post-translational modifications are known to play an important role in cancer progression and immune surveillance of tumors. In the present study, we compared the N-glycan profiles from 13 colorectal cancer tumor tissues and corresponding control colon tissues. The N-glycans were enzymatically released, purified, and labeled with 2-aminobenzoic acid. Aliquots were profiled by hydrophilic interaction liquid chromatography (HILIC-HPLC) with fluorescence detection and by negative mode MALDI-TOF-MS. Using partial least squares discriminant analysis to investigate the N-glycosylation changes in colorectal cancer, an excellent separation and prediction ability were observed for both HILIC-HPLC and MALDI-TOF-MS data. For structure elucidation, information from positive mode ESI-ion trap-MS/MS and negative mode MALDI-TOF/TOF-MS was combined. Among the features with a high separation power, structures containing a bisecting GlcNAc were found to be decreased in the tumor, whereas sulfated glycans, paucimannosidic glycans, and glycans containing a sialylated Lewis type epitope were shown to be increased in tumor tissues. In addition, core-fucosylated high mannose N-glycans were detected in tumor samples. In conclusion, the combination of HILIC and MALDI-TOF-MS profiling of N-glycans with multivariate statistical analysis demonstrated its potential for identifying N-glycosylation changes in colorectal cancer tissues and provided new leads that might be used as candidate biomarkers.

摘要

结直肠癌是全球第三大常见癌症,年发病率约为 100 万例,年死亡率约为 65.5 万例。因此,迫切需要确定新的靶点,以开发更敏感、可靠和特异的用于早期结肠癌检测的方法。翻译后修饰被认为在癌症的进展和肿瘤的免疫监视中起着重要作用。在本研究中,我们比较了 13 例结直肠癌肿瘤组织和相应对照结肠组织的 N-糖基化谱。N-糖基通过酶解释放、纯化并用 2-氨基苯甲酸标记。用亲水相互作用液相色谱(HILIC-HPLC)与荧光检测和负离子模式 MALDI-TOF-MS 对样品进行分析。使用偏最小二乘判别分析(PLS-DA)研究结直肠癌中的 N-糖基化变化,发现 HILIC-HPLC 和 MALDI-TOF-MS 数据均具有极好的分离和预测能力。为了进行结构解析,结合了正离子模式 ESI 离子阱-MS/MS 和负离子模式 MALDI-TOF/TOF-MS 的信息。在具有高分离能力的特征中,发现含有双触角 GlcNAc 的结构在肿瘤中减少,而硫酸化聚糖、少甘露糖型聚糖和含有唾液酸化 Lewis 型表位的聚糖在肿瘤组织中增加。此外,还在肿瘤样本中检测到核心岩藻糖基化高甘露糖型 N-聚糖。总之,HILIC 和 MALDI-TOF-MS 联合分析 N-糖基化图谱与多元统计分析相结合,证明了其在鉴定结直肠癌组织中 N-糖基化变化方面的潜力,并为可能作为候选生物标志物的新靶点提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/409c03e2664a/zjw0081242210007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/713069f29d61/zjw0081242210001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/625e23a03be6/zjw0081242210002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/487d01d4cd9c/zjw0081242210003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/3ffb3d51e02c/zjw0081242210004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/b3d993a8a787/zjw0081242210005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/419cf38b7a9f/zjw0081242210006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/409c03e2664a/zjw0081242210007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/713069f29d61/zjw0081242210001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/625e23a03be6/zjw0081242210002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/487d01d4cd9c/zjw0081242210003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/3ffb3d51e02c/zjw0081242210004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/b3d993a8a787/zjw0081242210005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/419cf38b7a9f/zjw0081242210006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b70/3434767/409c03e2664a/zjw0081242210007.jpg

相似文献

1
N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.基于液相色谱-质谱联用技术的结直肠癌组织 N-糖基化研究。
Mol Cell Proteomics. 2012 Sep;11(9):571-85. doi: 10.1074/mcp.M111.011601. Epub 2012 May 9.
2
Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS).采用液相色谱-基质辅助激光解吸飞行时间质谱法(MALDI-TOF-MS)研究结直肠癌组织中糖脂的异常糖基化。
Mol Cell Proteomics. 2013 Nov;12(11):3081-93. doi: 10.1074/mcp.M113.030387. Epub 2013 Jul 22.
3
Differential -glycosylation profiling of formalin-fixed paraffin-embedded (FFPE) invasive ductal carcinoma tissues using MALDI-TOF-MS.利用 MALDI-TOF-MS 对福尔马林固定石蜡包埋(FFPE)浸润性导管癌组织进行差异糖基化分析。
Mol Omics. 2021 Jun 14;17(3):394-404. doi: 10.1039/d0mo00150c.
4
Profiling N-glycans of the egg jelly coat of the sea urchin Paracentrotus lividus by MALDI-TOF mass spectrometry and capillary liquid chromatography electrospray ionization-ion trap tandem mass spectrometry systems.利用基质辅助激光解吸电离飞行时间质谱法和毛细管液相色谱电喷雾电离-离子阱串联质谱系统分析紫球海胆卵胶膜的N-聚糖
Mol Reprod Dev. 2017 May;84(5):401-407. doi: 10.1002/mrd.22794. Epub 2017 Apr 24.
5
MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.MALDI 质谱成像技术分析早晚期浆液性卵巢癌组织,揭示了具有阶段特异性的 N-聚糖。
Proteomics. 2019 Nov;19(21-22):e1800482. doi: 10.1002/pmic.201800482. Epub 2019 Aug 16.
6
Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.质谱分析显示结直肠癌组织中存在异常的 N-聚糖。
Glycobiology. 2019 May 1;29(5):372-384. doi: 10.1093/glycob/cwz005.
7
N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.结直肠癌细胞系的N-糖基化谱分析揭示岩藻糖基化与分化及尾型同源盒1(CDX1)/绒毛蛋白mRNA表达的关联。
Mol Cell Proteomics. 2016 Jan;15(1):124-40. doi: 10.1074/mcp.M115.051235. Epub 2015 Nov 4.
8
Differentiation of isomeric N-glycan structures by normal-phase liquid chromatography-MALDI-TOF/TOF tandem mass spectrometry.通过正相液相色谱 - 基质辅助激光解吸电离飞行时间/二级串联质谱法鉴别异构N - 聚糖结构
Anal Chem. 2006 Dec 15;78(24):8491-8. doi: 10.1021/ac0614137.
9
N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.福尔马林固定石蜡包埋组织上的N-聚糖基质辅助激光解吸电离成像质谱可实现对卵巢癌组织的描绘。
Mol Cell Proteomics. 2016 Sep;15(9):3003-16. doi: 10.1074/mcp.M116.059816. Epub 2016 Jul 13.
10
Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.治疗性免疫球蛋白G Fc糖基化谱分析方法的比较 - 第2部分:质谱方法
MAbs. 2015;7(4):732-42. doi: 10.1080/19420862.2015.1045173.

引用本文的文献

1
N-glycans in lung tissue specimens: a prospective target for enhanced cancer diagnosis and prognosis.肺组织标本中的N-聚糖:癌症诊断与预后强化的潜在靶点
J Transl Med. 2025 Aug 14;23(1):918. doi: 10.1186/s12967-025-06904-6.
2
Raider of the lost glycans - Localizing rare and frequently overlooked IgG glycans with sulfation or bisecting LacNAc.丢失聚糖的探索者——定位具有硫酸化或平分型N-乙酰乳糖胺的稀有且常被忽视的IgG聚糖
Front Mol Biosci. 2025 Jul 9;12:1593708. doi: 10.3389/fmolb.2025.1593708. eCollection 2025.
3
RHOGTPase-Related Gene Signature Predicts Prognosis, Immunotherapy Response, and Chemotherapy Sensitivity in Colon Cancer.

本文引用的文献

1
Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides.用于聚糖和糖肽的微尺度纯化和富集的棉亲水性相互作用 SPE 微吸头。
Anal Chem. 2011 Apr 1;83(7):2492-9. doi: 10.1021/ac1027116. Epub 2011 Mar 2.
2
Glycan changes: cancer metastasis and anti-cancer vaccines.糖链改变:癌症转移和抗癌疫苗。
J Biosci. 2010 Dec;35(4):665-73. doi: 10.1007/s12038-010-0073-8.
3
Novel glycan biomarkers for the detection of lung cancer.用于肺癌检测的新型聚糖生物标志物。
RHOGTP酶相关基因特征预测结肠癌的预后、免疫治疗反应和化疗敏感性。
Appl Biochem Biotechnol. 2025 May 10. doi: 10.1007/s12010-025-05262-9.
4
Regulation of intracellular activity of N-glycan branching enzymes in mammals.哺乳动物中 N-糖链分支酶的细胞内活性调节。
J Biol Chem. 2024 Jul;300(7):107471. doi: 10.1016/j.jbc.2024.107471. Epub 2024 Jun 13.
5
High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers after Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model.在同基因 SW480/SW620 结直肠癌细胞模型中敲低后的 -聚糖和蛋白质标志物的高通量质谱分析。
J Proteome Res. 2024 Apr 5;23(4):1379-1398. doi: 10.1021/acs.jproteome.3c00833. Epub 2024 Mar 20.
6
Recent Developments and Application of Mass Spectrometry Imaging in N-Glycosylation Studies: An Overview.质谱成像在N-糖基化研究中的最新进展与应用:综述
Mass Spectrom (Tokyo). 2024;13(1):A0142. doi: 10.5702/massspectrometry.A0142. Epub 2024 Feb 27.
7
Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression.利用多模态质谱成像分析结直肠癌疾病进展过程中的免疫细胞组成和N-糖基化。
Front Pharmacol. 2024 Jan 11;14:1337319. doi: 10.3389/fphar.2023.1337319. eCollection 2023.
8
Tolerable glycometabolic stress boosts cancer cell resilience through altered N-glycosylation and Notch signaling activation.可耐受的糖代谢应激通过改变 N-糖基化和 Notch 信号激活来增强癌细胞的恢复力。
Cell Death Dis. 2024 Jan 15;15(1):53. doi: 10.1038/s41419-024-06432-z.
9
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.发现用于肝细胞癌早期诊断的触珠蛋白糖肽生物标志物 panel。
Front Oncol. 2023 Oct 18;13:1213898. doi: 10.3389/fonc.2023.1213898. eCollection 2023.
10
N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm.非侵袭性和侵袭性管状内乳头状黏液性肿瘤中的 N-糖基化。
Sci Rep. 2023 Aug 14;13(1):13191. doi: 10.1038/s41598-023-39220-4.
J Proteome Res. 2011 Apr 1;10(4):1755-64. doi: 10.1021/pr101034t. Epub 2011 Mar 16.
4
High-mannose glycans are elevated during breast cancer progression.高甘露糖型聚糖在乳腺癌进展过程中升高。
Mol Cell Proteomics. 2011 Jan;10(1):M110.002717. doi: 10.1074/mcp.M110.002717. Epub 2010 Nov 19.
5
Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.与良性前列腺增生相比,前列腺癌患者血清 N-糖组中的核心岩藻糖基化和α2-3 唾液酸化显著增加。
Glycobiology. 2011 Feb;21(2):195-205. doi: 10.1093/glycob/cwq147. Epub 2010 Sep 22.
6
Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays.利用糖芯片测定人半乳糖凝集素的碳水化合物结合偏好。
Chembiochem. 2010 Jul 26;11(11):1563-73. doi: 10.1002/cbic.201000020.
7
Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry.基于凝集素的糖蛋白富集结合多重反应监测质谱法比较糖型异常的定量分析。
Anal Chem. 2010 Jun 1;82(11):4441-7. doi: 10.1021/ac1001965.
8
Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy.分子成像的 N-连接糖基化表明糖生物合成是癌症治疗的一个新靶点。
Clin Cancer Res. 2010 Jun 15;16(12):3205-14. doi: 10.1158/1078-0432.CCR-09-3331. Epub 2010 Apr 22.
9
The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.N-糖链中分支的 GlcNAc 抑制生长因子信号转导,从而延缓乳腺肿瘤的进展。
Cancer Res. 2010 Apr 15;70(8):3361-71. doi: 10.1158/0008-5472.CAN-09-2719.
10
2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination.2-吡啶基硼烷:一种用于通过还原胺化反应标记低聚糖的无毒还原剂。
Proteomics. 2010 Jun;10(12):2330-6. doi: 10.1002/pmic.200900804.